Off-label use of medication may be presented in these guidelines if a sufficient level of
evidence shows that it can be considered medically appropriate to a given condition and if …

Importance Perioperative cardiovascular complications occur in 3% of hospitalizations for
noncardiac surgery in the US. This review summarizes evidence regarding cardiovascular …

Guidelines, Aspirin, Clopidogrel, Ticagrelor, Prasugrel, Dual antiplatelet therapy, Acute
coronary syndromes, Coronary artery bypass grafting, Coronary artery disease, Drug-eluting …

In 2019, the Japanese Circulation Society published 2 guidelines in the field of coronary
artery disease (CAD):(1) a guideline for acute coronary syndrome (ACS) that integrated …

The scope of this focused update is limited to addressing recommendations on duration of
dual antiplatelet therapy (DAPT)(aspirin plus a P2Y12 inhibitor) in patients with coronary …

The recommendations listed in this CPG are, whenever possible, evidence based. In April
2013, an extensive evidence review was conducted, which included a literature review …

Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

Importance The current recommendation is for at least 12 months of dual antiplatelet therapy
after implantation of a drug-eluting stent. However, the optimal duration of dual antiplatelet …

Importance Guidelines recommend delaying noncardiac surgery in patients after coronary
stent procedures for 1 year after drug-eluting stents (DES) and for 6 weeks after bare metal …

BACKGROUND: Stent thrombosis remains among the most feared complications of
percutaneous coronary intervention (PCI) with stenting. However, data on its incidence and …